1. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker; 1992.
2. FDA. Guidance on statistical procedure for bioequivalence studies using a standard two-treatment crossover design. Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1992.
3. FDA. Guidance—Topical Dermatologic Corticosteroids: In vivo bioequivalence. Rockville, MD: Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1995.
4. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharm Biopharm 1987;15:657–680.
5. Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat Sci 1996;11:283–318.